NOD2-NLRP3 Axis and Asthma

NOD2-NLRP3 Axis and Asthma

Xulong Cai Department of Pediatrics, Affiliated Hospital 6 of Nantong University, Yancheng Third People’s Hospital, Yancheng, 224000, People’s Republic of ChinaCorrespondence: Xulong Cai, Email caixulong2017@163.comAbstract: Patients with asthma frequently experience recurrent symptoms including cou...

Full description

Saved in:

Bibliographic Details
Main Author:	Cai X
Format:	Article
Language:	English
Published:	Dove Medical Press 2025-05-01
Series:	Journal of Asthma and Allergy
Subjects:	NOD2 NLRP3 Inflammasome Asthma
Online Access:	https://www.dovepress.com/nod2-nlrp3-axis-and-asthma-peer-reviewed-fulltext-article-JAA
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

NOD-like receptors in pathogenesis of missed and spontaneous abortions
by: O. P. Lebedeva, et al.
Published: (2023-11-01)

Effect of puerarin administration on serum NOD-like receptor protein 3 (NLRP3) inflammasome, C1Q/TNF-related protein 3 (CTRP3) and lipoprotein-associated phospholipase 2 (LP-PLA2) levels
by: Wang Ge, et al.
Published: (2025-01-01)

Pulmonary fibrosis through the prism of NLRP3 inflammasome: mechanistic pathways and prospective therapeutic innovations
by: Mengxue Wang, et al.
Published: (2025-05-01)

NLRP11 is required for canonical NLRP3 and non-canonical inflammasome activation during human macrophage infection with mycobacteria
by: Mateusz Szczerba, et al.
Published: (2025-05-01)

Retinoic acid differently modulates NOD1/NOD2-mediated inflammatory responses in human macrophage subsets
by: Hala Ahmad, et al.
Published: (2025-07-01)

Inhibition of the NLRP3 inflammasome improves lifespan in animal murine model of Hutchinson–Gilford Progeria
by: Alvaro González‐Dominguez, et al.
Published: (2021-08-01)

Effect of experimental gestational diabetes and administration of glibenclamide on mRNA level of NLRP3-inflammasome and distribution of NLRP3+-cells in mesenteric lymph nodes in progeny
by: Т. М. Prozorova, et al.
Published: (2017-08-01)

Understanding the Role of NLRP3 Inflammasome in Acute Pancreatitis
by: Konstantinos Papantoniou, et al.
Published: (2024-11-01)

Salmonella-NLRP3 Inflammasome Crosstalk: Host Defense Activation Versus Bacterial Immune Evasion Strategies
by: Li Y, et al.
Published: (2025-04-01)

Bystander monocytic cells drive infection-independent NLRP3 inflammasome response to SARS-CoV-2
by: Leon L. Hsieh, et al.
Published: (2024-10-01)

NLRP3 inflammasome: a key player in neonatal brain injury
by: Cagla Kiser, et al.
Published: (2025-07-01)

The MFGE8/integrin β3 axis mitigates experimental neutrophilic asthma by suppressing NLRP3-Caspase-1 pathway-mediated NETosis
by: Shanshan Wang, et al.
Published: (2025-07-01)

Targeting the NLRP3-ROS Axis: Disrupting the Oxidative-Inflammatory Vicious Cycle in Intracerebral Hemorrhage
by: Cao L, et al.
Published: (2025-07-01)

Dihydromyricetin mitigates epilepsy and cognitive impairment via NLRP3 inhibition in rats
by: Qing Li, et al.
Published: (2025-04-01)

A nod to paratuberculosis: NOD1 and NOD2 expression in the pathological spectrum of Mycobacterium avium subsp. paratuberculosis infection in cattle
by: David Zapico, et al.
Published: (2025-05-01)

Global Research Trends and Focus on the Link Between Heart Failure and NLRP3 Inflammasome: A Bibliometric Analysis From 2010 to 2024
by: Lian Y, et al.
Published: (2025-02-01)

Molecular Mechanism of NLRP3 Inflammasome in Inflammatory Diseases and Tumors
by: Le‐Lan Gong, et al.
Published: (2025-07-01)

Research and progress of cGAS/STING/NLRP3 signaling pathway: a mini review
by: Ke-qian Chen, et al.
Published: (2025-05-01)

Targeting NLRP3 signaling with a novel sulfonylurea compound for the treatment of vascular cognitive impairment and dementia
by: Adnan Akif, et al.
Published: (2025-06-01)

Enhanced Cardiomyocyte NLRP3 Inflammasome‐Mediated Pyroptosis Promotes d‐Galactose–Induced Cardiac Aging
by: Wen‐bin Liu, et al.
Published: (2024-07-01)

Inhibition of RACK1‐Mediated NLRP3 Oligomerization (Active Conformation) Ameliorates Acute Respiratory Distress Syndrome
by: Jian Cui, et al.
Published: (2025-07-01)

NOX2/NLRP3-Inflammasome-Dependent Microglia Activation Promotes As(III)-Induced Learning and Memory Impairments in Developmental Rats
by: Linlin Zhang, et al.
Published: (2025-06-01)

UFMylation of NLRP3 Prevents Its Autophagic Degradation and Facilitates Inflammasome Activation
by: Jiongjie Jing, et al.
Published: (2025-04-01)

NLRP3 Inflammasome-Mediated Osteoarthritis: The Role of Epigenetics
by: Yuzhou Liu, et al.
Published: (2025-01-01)

NLRP3 deficiency abrogates silica-induced neutrophil infiltration, pulmonary damage and fibrosis
by: Maggie Lam, et al.
Published: (2025-03-01)

Apigenin inhibits NLRP3 inflammasome activation in monocytes and macrophages independently of CD38
by: Knut Husø Lauritzen, et al.
Published: (2025-01-01)

Assembly and activation of the NLRP3 inflammasome and cytokine quantification in response to exercise in adults with different metabolic conditions: a systematic review
by: Salma Verenice Cristerna-Huerta, et al.
Published: (2025-07-01)

Bridging inflammation and venous thrombosis: the NLRP3 inflammasome connection
by: Jian Wu, et al.
Published: (2025-05-01)

CMPK2 promotes NLRP3 inflammasome activation via mtDNA‐STING pathway in house dust mite‐induced allergic rhinitis
by: YaoMing Zheng, et al.
Published: (2025-01-01)

The NLRP3 inflammasome: a therapeutic target of phytochemicals in treating atherosclerosis (a systematic review)
by: Yongchao Liu, et al.
Published: (2025-05-01)

Electroacupuncture Inhibits NLRP3-Mediated Microglial Pyroptosis to Ameliorate Chronic Neuropathic Pain in Rats
by: Kui W, et al.
Published: (2025-03-01)

Expression of innate immunity genes in human hematopoietic stem/progenitor cells – single cell RNA-seq analysis
by: Justyna Jarczak, et al.
Published: (2025-04-01)

Clusterin deficiency exacerbates cholestatic liver disease through ER stress and NLRP3 inflammasome activation
by: Hye-Young Seo, et al.
Published: (2025-03-01)

Caspase-11 and NLRP3 exacerbate systemic Klebsiella infection through reducing mitochondrial ROS production
by: Yuqi Zhou, et al.
Published: (2025-02-01)

GDF11 protects against mitochondrial-dysfunction-dependent NLRP3 inflammasome activation to attenuate osteoarthritis
by: Pengfei Zhang, et al.
Published: (2025-07-01)

Research progress on NLRP3 inflammasome regulation of periodontitis
by: LI Xuejing, et al.
Published: (2024-02-01)

NLRP12-associated periodic syndrome: A description of the authors' own observation and an analysis of literature data
by: M. F. Dubko, et al.
Published: (2017-04-01)

NLRP3 inflammasome inhibits mitophagy during the progression of temporal lobe epilepsy
by: Mengqian Wu, et al.
Published: (2025-05-01)

The Emerging Role of Colchicine to Inhibit NOD-like Receptor Family, Pyrin Domain Containing 3 Inflammasome and Interleukin-1β Expression in In Vitro Models
by: Tri Astiawati, et al.
Published: (2025-03-01)

Verteporfin attenuates NLRP3 inflammasome activation to alleviate gout arthritis flares
by: Daniel C. Shippy, et al.
Published: (2025-07-01)